Free delivery on orders over R750. Earn Skin Spots with each product purchased.
R547,00
DermExcel Follicure is a maximum strength medicated scalp treatment to relieve itching, irritation, redness, flaking, and scaling associated with dandruff and seborrheic dermatitis.
DermExcel Follicure is a powerful formula that combines 2% Salicylic acid and 2% Zinc pyrithione for maximum effectiveness and life-changing results.
DermExcel Follicure is a maximum strength medicated scalp treatment to relieve itching, irritation, redness, flaking, and scaling associated with dandruff and seborrheic dermatitis.
DermExcel Follicure is a powerful formula that combines 2% Salicylic acid and 2% Zinc pyrithione for maximum effectiveness and life-changing results.
Key Benefits of DermExcel Follicure Scalp Treatment:
DermExcel™ takes an easy, effective and affordable approach to evaluation and treatment of the skin. All active ingredients, and the concentrations and dosing protocols in which they are used, are supported by data published in the peer-reviewed medical literature. Targeted treatments to improve skin conditions and maintain skin health.
Zinc Pyrithione: 2%
Salicylic acid: 2%
Aqua, Polyethylene Glycol, Coco-Glucoside, Cocoamidopropyl Betaine, Sodium Lauroyl Sarcosinate, Salicylic acid, Zinc Pyrithione, Phenoxyethanol & Ethyl hexyl Glycerin, Acrylates Copolymer, Triethanolamine, Coco-Glucoside & Glyceryl Oleate
Only logged in customers who have purchased this product may leave a review.
Receive up to 20% off on your next Skin Spot order during our Black Friday Sale.
Duration: Sale will go live on Thursday, 27 November at 11:55pm and will end on 1 December 2025 at 5pm.
Terms & Conditions: Orders will be dispatched within 3–14 days after purchase. All orders will include complimentary samples while stocks last. Treatment Kits, which are already reduced, are excluded from the sale. Loyalty points will still be earned on all orders, and existing loyalty points may be redeemed during the Black Friday Sale.
Reviews
There are no reviews yet.